Polydex Pharmaceuticals Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a POLXF research report →
Price Chart
About the company
Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry.
- CEO
- George G. Usher
- IPO
- 1983
- Employees
- 20
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on POLXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.82M
- P/E
- -2.76
- PEG
- 0.08
- P/S
- 1.52
- P/B
- 1.76
- EV/EBITDA
- -10.66
- Div Yield
- 0.00%
- Gross Margin
- -2.05%
- Op Margin
- -26.23%
- Net Margin
- -49.08%
- ROE
- -53.04%
- ROIC
- -25.50%
Latest fiscal year · YoY change
- Revenue
- $4.48M-7.1%
- Gross Profit
- $-91,725-387.5%
- Op Income
- $-1,175,609
- Net Income
- $-2,199,358-38.2%
- EPS
- $-0.72-38.5%
- OCF Growth
- -134.8%
- FCF Growth
- -114.0%
- 52W High
- $2.01
- 52W Low
- $0.55
- 50D MA
- $1.93
- 200D MA
- $1.07
- Beta
- 0.45
- RSI (14)
- 60
- Avg Volume
- 5.53K
No earnings-call transcripts are available for POLXF yet.
- Free Float
- 86.9%
- Shares Outstanding
- 3.43M
- Float Shares
- 2.98M
Our POLXF coverage
Recent articles, reports, and earnings notes.
No research on POLXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate POLXF report →Polydex Pharmaceuticals (OTCMKTS:POLXF) Share Price Passes Below 200-Day Moving Average – Here’s What Happened
defenseworld.net · Apr 17
BioCryst Pharmaceuticals (NASDAQ:BCRX) & Polydex Pharmaceuticals (OTCMKTS:POLXF) Head to Head Analysis
defenseworld.net · Apr 5
Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock Price Passes Below 200-Day Moving Average – Should You Sell?
defenseworld.net · Mar 28
Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock Passes Below 200-Day Moving Average – Here’s What Happened
defenseworld.net · Mar 4
Critical Review: Polydex Pharmaceuticals (OTCMKTS:POLXF) and Nektar Therapeutics (NASDAQ:NKTR)
defenseworld.net · Feb 10
Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock Crosses Below 200 Day Moving Average – What’s Next?
defenseworld.net · Jan 29
Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?
defenseworld.net · Nov 22
Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business Combination
globenewswire.com · Aug 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.